Endometriosis and IVF: What the Evidence Says About Surgery First

Usually not, if the reason offered is to improve your chances of a baby. ESHRE's 2022 endometriosis guideline does not recommend routine surgery before assisted reproduction for rASRM stage I or II endometriosis, or for ovarian endometrioma.

The reasoning is that the benefit has not been demonstrated. The guideline describes the effect of pre-treatment surgery on live birth rates as unclear — which is a different and more honest statement than saying it helps.

• Stage I/II endometriosis — routine surgery before ART not recommended.
• Ovarian endometrioma — routine surgery before ART not recommended.
• Surgery may still improve pain, which is a valid reason on its own.
• Specific findings can change the answer — see below.

None of that means surgery is never right. It means 'it will improve your IVF odds' is not currently a supported reason for it.

When there is a specific finding that surgery addresses, rather than a general hope of improving the cycle. The guideline and subsequent commentary identify a narrow set of situations.

• Hydrosalpinx — a fluid-filled tube, which has its own strong evidence.
• Pain that warrants treatment in its own right.
• Rapid growth of an endometrioma.
• Large lesions physically obstructing access to the ovary at egg retrieval.

That last one is practical rather than biological: if the surgeon cannot reach the follicles, the cycle cannot proceed regardless of what the evidence says about live birth.

Where the tube is involved, the evidence is much firmer — our article on tubal blockages and hydrosalpinx covers what the Cochrane review found for salpingectomy before IVF.

• IVF vs ICSI — What the Difference Is, and When ICSI Actually Helps (2026)
• IVF Side Effects: What OHSS Is and How It Is Prevented
• After a Failed IVF Cycle: What Is Worth Investigating
• Recurrent Implantation Failure: What the 2023 Definition Changed
• What Is Diminished Ovarian Reserve? What the Tests Do and Do Not Tell You (2026)
• What Is Assisted Hatching — And Does the Evidence Support It? (2026)
• Ayurveda and Fertility: What Has Actually Been Tested

Potentially ovarian response. Removing an endometrioma means operating on the ovary itself, and meta-analyses indicate that surgery does not consistently improve ART outcomes while it may mean higher gonadotrophin doses are needed for stimulation.

That is the trade-off the routine-surgery approach tends to leave out. An intervention with an unproven benefit and a plausible cost to egg yield is a different proposition from one that simply might not help.

Surgery may facilitate spontaneous conception within six to twelve months for some women, which is a real benefit — but it belongs to a different plan from one that goes straight to IVF.

Less than is often implied. ESHRE 2022 states that both GnRH antagonist and agonist protocols can be offered according to patient and clinician preference, because no difference in pregnancy or live birth rate has been demonstrated between them.

The guideline is more directive on one point: it issued a strong recommendation against the routine use of prolonged GnRH agonist pretreatment. That is a practice still encountered, and 'strong recommendation against' is unusually firm language for this field.

Our comparison of antagonist and agonist protocols covers what the wider trial evidence shows outside endometriosis.

Because the guideline changed and practice has not caught up everywhere. Operating before IVF was standard for years, and a recommendation that something is no longer routinely indicated moves through clinics slowly.

There is also a structural reason. Surgery for endometriosis has a genuine benefit for pain, and pain is often the reason a woman was referred in the first place. A conversation that starts with pain can end with an operation justified on fertility grounds without anyone noticing the switch.

• The pain indication is real and separate from the fertility one.
• A recommendation against routine surgery is not a recommendation against surgery.
• Stage and specific findings change the answer.
• Ask which of the two reasons is being offered.

None of this is a reason to refuse surgery. It is a reason to be clear about which question it is answering, because the evidence differs sharply between them.

Endometriosis attracts confident advice out of proportion to the evidence behind it, and most of the confident advice is surgical.

• Routine surgery before IVF is not supported for stage I/II or endometrioma.
• Prolonged GnRH agonist pretreatment is specifically recommended against.
• No diet or supplement has been shown to improve IVF outcomes in endometriosis.
• A diagnosis of endometriosis does not by itself mean IVF is required.

The useful question before consenting is simple: what is this operation for? If the answer is pain, that is a real indication. If the answer is 'to improve your IVF chances', the guideline does not currently support it.